Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue.
Sparicio
Donatella
D
Landoni
Giovanni
G
Zangrillo
Alberto
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D016534:Cardiac Output, High / Q000139:chemically induced / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000188:drug therapy*; D008751:Methylene Blue / Q000008:administration & dosage / Q000627:therapeutic use*; D009638:Norepinephrine / Q000008:administration & dosage*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage*
D000806:Angiotensin-Converting Enzyme Inhibitors; D014662:Vasoconstrictor Agents; D008751:Methylene Blue; D009638:Norepinephrine